HEADER TRANSFERASE 23-JUL-15 5CSX TITLE CRYSTAL STRUCTURE OF B-RAF IN COMPLEX WITH BI 882370 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 442-721; COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF,P94,V-RAF MURINE SARCOMA VIRAL ONCOGENE COMPND 6 HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.BADER,H.STADTMULLER,S.STEURER REVDAT 5 10-JAN-24 5CSX 1 REMARK HETSYN REVDAT 4 29-JUL-20 5CSX 1 COMPND REMARK HETNAM SITE REVDAT 3 25-APR-18 5CSX 1 REMARK REVDAT 2 16-MAR-16 5CSX 1 JRNL REVDAT 1 09-MAR-16 5CSX 0 JRNL AUTH I.C.WAIZENEGGER,A.BAUM,S.STEURER,H.STADTMULLER,G.BADER, JRNL AUTH 2 O.SCHAAF,P.GARIN-CHESA,A.SCHLATTL,N.SCHWEIFER,C.HASLINGER, JRNL AUTH 3 F.COLBATZKY,S.MOUSA,A.KALKUHL,N.KRAUT,G.R.ADOLF JRNL TITL A NOVEL RAF KINASE INHIBITOR WITH DFG-OUT-BINDING MODE: HIGH JRNL TITL 2 EFFICACY IN BRAF-MUTANT TUMOR XENOGRAFT MODELS IN THE JRNL TITL 3 ABSENCE OF NORMAL TISSUE HYPERPROLIFERATION. JRNL REF MOL.CANCER THER. V. 15 354 2016 JRNL REFN ESSN 1538-8514 JRNL PMID 26916115 JRNL DOI 10.1158/1535-7163.MCT-15-0617 REMARK 2 REMARK 2 RESOLUTION. 2.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.07 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 9441 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.283 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.900 REMARK 3 FREE R VALUE TEST SET COUNT : 925 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.51 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.58 REMARK 3 REFLECTION IN BIN (WORKING SET) : 692 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.34 REMARK 3 BIN R VALUE (WORKING SET) : 0.3550 REMARK 3 BIN FREE R VALUE SET COUNT : 62 REMARK 3 BIN FREE R VALUE : 0.3440 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2087 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 27 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.40000 REMARK 3 B22 (A**2) : 5.55000 REMARK 3 B33 (A**2) : -2.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.827 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.347 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.259 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.687 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.885 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2132 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1493 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2880 ; 1.151 ; 1.983 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3610 ; 0.994 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 258 ; 6.318 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 88 ;32.827 ;23.750 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 371 ;14.014 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;13.757 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 316 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2322 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 422 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1295 ; 1.429 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 528 ; 0.251 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2080 ; 2.678 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 837 ; 3.663 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 800 ; 5.863 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5CSX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1000212116. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-10 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10430 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.510 REMARK 200 RESOLUTION RANGE LOW (A) : 58.070 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.7200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.51 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.30 REMARK 200 R MERGE FOR SHELL (I) : 0.44100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3C4C REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.21150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.21150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 24.68750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 58.06800 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 24.68750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 58.06800 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 51.21150 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 24.68750 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 58.06800 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 51.21150 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 24.68750 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 58.06800 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 926 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 442 REMARK 465 PRO A 443 REMARK 465 ARG A 444 REMARK 465 ASP A 445 REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 TRP A 604 REMARK 465 SER A 605 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 PHE A 610 REMARK 465 GLU A 611 REMARK 465 GLN A 612 REMARK 465 LEU A 613 REMARK 465 SER A 630 REMARK 465 ASN A 631 REMARK 465 LEU A 721 REMARK 465 SER A 722 REMARK 465 GLY A 723 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASP A 448 CG OD1 OD2 REMARK 480 VAL A 487 CG1 CG2 REMARK 480 THR A 488 OG1 CG2 REMARK 480 GLN A 493 CD OE1 NE2 REMARK 480 GLN A 494 CG CD OE1 NE2 REMARK 480 GLN A 496 CD OE1 NE2 REMARK 480 LYS A 499 CD CE NZ REMARK 480 ARG A 506 NE CZ NH1 NH2 REMARK 480 LYS A 507 CE NZ REMARK 480 LYS A 522 CG CD CE NZ REMARK 480 LYS A 547 CE NZ REMARK 480 THR A 599 OG1 CG2 REMARK 480 ARG A 603 CZ NH1 NH2 REMARK 480 ARG A 671 CG CD NE CZ NH1 NH2 REMARK 480 LYS A 698 NZ REMARK 480 ARG A 719 CD NE CZ NH1 NH2 REMARK 480 GLU A 720 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 487 98.89 -164.40 REMARK 500 ARG A 575 -9.55 77.65 REMARK 500 ASP A 576 42.70 -155.57 REMARK 500 ASN A 588 -41.36 -132.70 REMARK 500 ARG A 701 -63.80 3.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 54J A 801 DBREF 5CSX A 442 721 UNP P15056 BRAF_HUMAN 442 721 SEQADV 5CSX PRO A 443 UNP P15056 ARG 443 ENGINEERED MUTATION SEQADV 5CSX ALA A 543 UNP P15056 ILE 543 ENGINEERED MUTATION SEQADV 5CSX SER A 544 UNP P15056 ILE 544 ENGINEERED MUTATION SEQADV 5CSX LYS A 551 UNP P15056 ILE 551 ENGINEERED MUTATION SEQADV 5CSX ARG A 562 UNP P15056 GLN 562 ENGINEERED MUTATION SEQADV 5CSX ASN A 588 UNP P15056 LEU 588 ENGINEERED MUTATION SEQADV 5CSX SER A 630 UNP P15056 LYS 630 ENGINEERED MUTATION SEQADV 5CSX GLU A 667 UNP P15056 PHE 667 ENGINEERED MUTATION SEQADV 5CSX SER A 673 UNP P15056 TYR 673 ENGINEERED MUTATION SEQADV 5CSX ARG A 688 UNP P15056 ALA 688 ENGINEERED MUTATION SEQADV 5CSX SER A 706 UNP P15056 LEU 706 ENGINEERED MUTATION SEQADV 5CSX ARG A 709 UNP P15056 GLN 709 ENGINEERED MUTATION SEQADV 5CSX GLU A 713 UNP P15056 SER 713 ENGINEERED MUTATION SEQADV 5CSX GLU A 716 UNP P15056 LEU 716 ENGINEERED MUTATION SEQADV 5CSX GLU A 720 UNP P15056 SER 720 ENGINEERED MUTATION SEQADV 5CSX SER A 722 UNP P15056 EXPRESSION TAG SEQADV 5CSX GLY A 723 UNP P15056 EXPRESSION TAG SEQRES 1 A 282 GLY PRO ARG ASP SER SER ASP ASP TRP GLU ILE PRO ASP SEQRES 2 A 282 GLY GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER SEQRES 3 A 282 PHE GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL SEQRES 4 A 282 ALA VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN SEQRES 5 A 282 GLN LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG SEQRES 6 A 282 LYS THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SEQRES 7 A 282 SER THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS SEQRES 8 A 282 GLU GLY SER SER LEU TYR HIS HIS LEU HIS ALA SER GLU SEQRES 9 A 282 THR LYS PHE GLU MET LYS LYS LEU ILE ASP ILE ALA ARG SEQRES 10 A 282 GLN THR ALA ARG GLY MET ASP TYR LEU HIS ALA LYS SER SEQRES 11 A 282 ILE ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU SEQRES 12 A 282 HIS GLU ASP ASN THR VAL LYS ILE GLY ASP PHE GLY LEU SEQRES 13 A 282 ALA THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE SEQRES 14 A 282 GLU GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU SEQRES 15 A 282 VAL ILE ARG MET GLN ASP SER ASN PRO TYR SER PHE GLN SEQRES 16 A 282 SER ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU SEQRES 17 A 282 MET THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG SEQRES 18 A 282 ASP GLN ILE ILE GLU MET VAL GLY ARG GLY SER LEU SER SEQRES 19 A 282 PRO ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ARG SEQRES 20 A 282 MET LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG SEQRES 21 A 282 ASP GLU ARG PRO SER PHE PRO ARG ILE LEU ALA GLU ILE SEQRES 22 A 282 GLU GLU LEU ALA ARG GLU LEU SER GLY HET 54J A 801 40 HET GLC A 802 12 HETNAM 54J N-(3-{5-[(1-ETHYLPIPERIDIN-4-YL)(METHYL)AMINO]-3- HETNAM 2 54J (PYRIMIDIN-5-YL)-1H-PYRROLO[3,2-B]PYRIDIN-1-YL}-2,4- HETNAM 3 54J DIFLUOROPHENYL)PROPANE-1-SULFONAMIDE HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 2 54J C28 H33 F2 N7 O2 S FORMUL 3 GLC C6 H12 O6 FORMUL 4 HOH *27(H2 O) HELIX 1 AA1 GLN A 494 ARG A 506 1 13 HELIX 2 AA2 LEU A 537 ALA A 543 1 7 HELIX 3 AA3 GLU A 549 LYS A 570 1 22 HELIX 4 AA4 LYS A 578 ASN A 580 5 3 HELIX 5 AA5 SER A 616 MET A 620 5 5 HELIX 6 AA6 ALA A 621 MET A 627 1 7 HELIX 7 AA7 SER A 634 GLY A 652 1 19 HELIX 8 AA8 ASN A 661 ARG A 671 1 11 HELIX 9 AA9 ASP A 677 VAL A 681 5 5 HELIX 10 AB1 PRO A 686 LEU A 697 1 12 HELIX 11 AB2 LYS A 700 ARG A 704 5 5 HELIX 12 AB3 SER A 706 GLU A 720 1 15 SHEET 1 AA1 5 THR A 458 SER A 465 0 SHEET 2 AA1 5 GLY A 469 LYS A 475 -1 O LYS A 473 N GLN A 461 SHEET 3 AA1 5 ASP A 479 LEU A 485 -1 O MET A 484 N THR A 470 SHEET 4 AA1 5 ALA A 526 GLN A 530 -1 O THR A 529 N ALA A 481 SHEET 5 AA1 5 PHE A 516 SER A 520 -1 N GLY A 518 O VAL A 528 SHEET 1 AA2 3 GLY A 534 SER A 536 0 SHEET 2 AA2 3 ILE A 582 HIS A 585 -1 O LEU A 584 N SER A 535 SHEET 3 AA2 3 THR A 589 ILE A 592 -1 O THR A 589 N HIS A 585 CISPEP 1 LYS A 522 PRO A 523 0 1.29 CRYST1 49.375 116.136 102.423 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020253 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008611 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009763 0.00000